2017-06-292026-03-272017-06-292008Alberto Darío Ramírez González0270-647410.1523/JNEUROSCI.4848-08.2008https://doi.org/10.1523/JNEUROSCI.4848-08.2008https://repositorio.inprf.gob.mx/handle/123456789/5291engacceso cerradoAnalysis of VarianceAnimalsAnimals, NewbornBicuculline-pharmacologyBiophysics-methodsCalcium-metabolismCalcium Channel Blockers-pharmacologyChelating Agents-pharmacologyCyclopropanes-pharmacologyEgtazic Acid-analogs & derivativesEgtazic Acid-pharmacologyElectric Stimulation-methodsExcitatory Amino Acid Antagonists-pharmacologyGABA Antagonists-pharmacologyGlycine-analogs & derivativesGlycine-pharmacologyHippocampus-cytologyInterneurons-drug effectsInterneurons-physiologyLong-Term Potentiation-drug effectsLong-Term Potentiation-physiologyLysine-analogs & derivativesLysine-metabolismMaleMembrane Potentials-drug effectsMembrane Potentials-physiologyMossy Fibers, Hippocampal-drug effectsMossy Fibers, Hippocampal-physiologyNeuronal Plasticity-drug effectsNeuronal Plasticity-physiologyNicotinic Antagonists-pharmacologyNimodipine-pharmacologyPatch-Clamp Techniques-methodsPolyamines-pharmacologyRatsRats, Sprague-DawleyTime Factorsarticle1529-240152Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz14042-14055United States28Mossy fiberLTPLTDCalcium-impermeable AMPARsCA3 interneuronsFeedforward inhibition